FDA Crackdown On Anti-Aging Imports Signals "Major Enforcement Initiative"
This article was originally published in The Tan Sheet
Executive Summary
Increased scrutiny of anti-aging products with sunscreen ingredients entering the U.S. presages "a major enforcement initiative" against personal care product firms making noncompliant claims, according to a food and drug attorney who worked at FDA on import enforcement
You may also be interested in...
Nu Skin Unfazed By Allegations Of China Violations, Projects More Growth
Following allegations from short seller Citron Research that it operates a “pyramid compensation scheme” in China, Nu Skin gives investors a peek into its business model. The firm recorded sales growth of 40% in its second quarter, driven by a 152% jump in China, and “the best is yet to come,” Nu Skin says.
Nu Skin Unfazed By Allegations Of China Violations, Projects More Growth
Following allegations from short seller Citron Research that it operates a “pyramid compensation scheme” in China, Nu Skin gives investors a peek into its business model. The firm recorded sales growth of 40% in its second quarter, driven by a 152% jump in China, and “the best is yet to come,” Nu Skin says.
Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows
Analysts agree cosmeceuticals remain a promising growth vehicle despite the notable regulatory questions the products can create.